Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Go to hell

<< Previous

Bullboard Posts

Next >>

Comment by canadapieton Jul 11, 2022 4:34pm

95 Views

Post# 34816245

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Go to hell

Counting from preliminary + trial 1a + little time of 1b....????!!!

longterm56 - (7/11/2022 4:23:27 PM)

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Go to hell

2 years? Kind of an exaggeration. -LT

canadapiet wrote:The fact that after 2 years of trials there is still no sign of a real "effect" on the tumors should tell you something. At best, there may be a sign but it will for sure not be "earthshattering"!
So the necessary capital increase is hanging over the actual shareprice!
How can a CEO tell the community they are in "a very strong position"???!!!!
They need in the very short time a lot of money if they will continue the more costing new trials!! (and there is also the convertible.....)
But maybe, perhaps, they can convince a Chinese B Pharma .........??

GLA